Efficacy and Safety of Ensifentrine in Chinese Patients with Chronic Obstructive Pulmonary Disease: The ENHANCE-CHINA Randomized Clinical Trial
Yumin Zhou·Nanshan Zhong·Dongbo Tian·Guoru Yang·Junzhen Gao·Zonghui Wei·Tiebo Yang·Ting Yang·Limin Wang·Fan Wu·Chuntao Liu·Juan Chen·Wei Gu·Xiao Liu·Pixin Ran·Yi Hu·Yuanrong Dai·Limin Dong·Liping Peng·Jie Cao·Zihui Wang·Feng Xu·Zhu Xiao·Dan Zhu·Charlie Degui Chen
Ensifentrine significantly improved lung function and showed efficacy benefits in symptoms, quality of life improvement, and exacerbation reduction in Chinese individuals with COPD.